₹417.6
▼ -4.3 -1.02%
18 Jul 2026
BSE Listed · Pharmaceuticals
FDC Ltd. (531599)
Volume: 3,336Avg Vol 1W: 2,869Avg Vol 1M: 12,22452W Range:₹314.75₹528.3
Key Ratios
Checked 8h agoMarket Cap₹6,799 Cr
Current Price₹417.6
Previous Close₹421.9
High / Low (52w)₹528.3 / ₹314.75
Volume3,336
Avg Vol (1W)2,869
Avg Vol (1M)12,224
Stock P/E22.89
Book Value₹152.64
Dividend Yield1.19%
ROE11.32%
ROA9.64%
Revenue (TTM)—
Revenue Growth8.5%
Profit Margin12.96%
Total Debt₹10,97,000 Cr
Shares Outstanding16 Cr
Face Value₹1
EPS (TTM)₹18.24
P/B2.74
Debt / Equity0.01
50 DMA₹397.67
200 DMA₹395.82
Day change-1.02%
Price Chart
₹417.6▼ 14.64% · 1Y
2025-07-182026-07-17
20-day avg volume: 13K shares
Pros
- Company is almost debt-free.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹638 Cr | ₹514 Cr | ₹464 Cr | ₹492 Cr | ₹648 Cr | ₹473 Cr | ₹465 Cr | ₹585 Cr |
| EBITDA | ₹164 Cr | ₹91 Cr | ₹52 Cr | ₹55 Cr | ₹161 Cr | ₹39 Cr | ₹58 Cr | ₹142 Cr |
| Net Profit | ₹119 Cr | ₹72 Cr | ₹37 Cr | ₹39 Cr | ₹121 Cr | ₹28 Cr | ₹28 Cr | ₹103 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,126 Cr | ₹1,134 Cr | ₹1,413 Cr | ₹1,430 Cr | ₹1,604 Cr | ₹1,834 Cr | ₹2,045 Cr | ₹2,199 Cr |
| EBITDA | ₹243 Cr | ₹241 Cr | ₹324 Cr | ₹393 Cr | ₹292 Cr | ₹262 Cr | ₹400 Cr | ₹362 Cr |
| Net Profit | ₹174 Cr | ₹170 Cr | ₹240 Cr | ₹301 Cr | ₹216 Cr | ₹194 Cr | ₹305 Cr | ₹267 Cr |
| EPS | 9.76 | 9.74 | 13.94 | 17.73 | 12.81 | 11.66 | 18.58 | 16.39 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,505 Cr | ₹1,640 Cr | ₹1,813 Cr | ₹1,956 Cr | ₹2,270 Cr | ₹2,343 Cr | ₹2,468 Cr | ₹2,714 Cr |
| Total Liabilities | ₹229 Cr | ₹195 Cr | ₹266 Cr | ₹222 Cr | ₹314 Cr | ₹362 Cr | ₹371 Cr | ₹433 Cr |
| Equity | ₹1,276 Cr | ₹1,445 Cr | ₹1,547 Cr | ₹1,734 Cr | ₹1,956 Cr | ₹1,981 Cr | ₹2,097 Cr | ₹2,281 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹218 Cr | ₹186 Cr | ₹335 Cr | ₹302 Cr | ₹241 Cr | ₹232 Cr | ₹325 Cr | ₹420 Cr |
| Investing | ₹20 Cr | ₹-120 Cr | ₹-98 Cr | ₹-77 Cr | ₹-145 Cr | ₹11 Cr | ₹-17 Cr | ₹-200 Cr |
| Financing | ₹-169 Cr | ₹0 Cr | ₹-142 Cr | ₹-129 Cr | ₹-10 Cr | ₹-180 Cr | ₹-202 Cr | ₹-92 Cr |
| Free Cash Flow | ₹218 Cr | ₹186 Cr | ₹335 Cr | ₹302 Cr | ₹241 Cr | ₹232 Cr | ₹325 Cr | ₹420 Cr |
Shareholding
Promoter 69.66% Institutions 8.69% Public 21.65%
Efficiency & Working Capital
ROCE15.2%
Interest Coverage80.2
Dividend Payout—
Debtor Days19 d
Inventory Days65 d
Payable Days36 d
Cash Conversion Cycle48 d
Working Capital Days84 d
Shareholding Details
As of 2026-03-31
Promoter69.7%
FII2.4%
DII6.3%
Institutions8.7%
Public21.6%
Promoter Pledge0%
No. of Shareholders52,730
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.5% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% |
| FIIs | 2.1% | 2.4% | 2.4% | 2.6% | 2.5% | 2.6% | 2.7% | 2.6% | 2.4% | 2.4% | 2.3% | 2.4% |
| DIIs | 9% | 8% | 7.6% | 6.9% | 6.7% | 6% | 6.1% | 6.4% | 7.2% | 6.8% | 6.3% | 6.3% |
| Public | 19.5% | 19.9% | 20.3% | 20.8% | 21.1% | 21.7% | 21.6% | 21.4% | 20.8% | 21.1% | 21.8% | 21.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 56,717 | 56,928 | 55,341 | 52,377 | 50,634 | 55,400 | 55,228 | 53,880 | 54,445 | 54,157 | 53,788 | 52,730 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Nomita R Chandavarkar | Shareholding of Promoter and Promoter Group | 22.7% | 3.69 Cr |
| Nandan Mohan Chandavarkar (in The Capacity Of Trustee Sandhya Mohan Chandavarkar Trust) | Shareholding of Promoter and Promoter Group | 11% | 1.79 Cr |
| Nandan Mohan Chandavarkar (in The Capacity Of Trustee Mohan Anand Chandavarkar Trust) | Shareholding of Promoter and Promoter Group | 10.8% | 1.76 Cr |
| Leo Advisors Pvt Ltd (in The Capacity Of Ameya Family Discretionary Trust) | Shareholding of Promoter and Promoter Group | 9.2% | 1.49 Cr |
| Aditi C Bhanot | Shareholding of Promoter and Promoter Group | 6.8% | 1.11 Cr |
| Ameya Ashok Chandavarkar | Shareholding of Promoter and Promoter Group | 6.1% | 99,23,930 |
| Nandan Mohan Chandavarkar | Shareholding of Promoter and Promoter Group | 3.1% | 50,41,086 |
| Icici Prudential Smallcap Fund | Public Shareholding | 2.9% | 46,46,981 |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | Public Shareholding | 2.6% | 42,75,331 |
| Virgo Advisors Pvt Ltd(trustee Of Aditi Family Discretionary Trust) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Meera Ramdas Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mohan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sandhya Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Alpana Nandan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anandi Nandan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shivani Nandan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vasant Anand Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Capt. Girish Anand Kaushik | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ashok Anand Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mangala Ashok Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shaivi Ameya Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shreya Ameya Chandavar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Veera Ameya Chandavar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aryatara Traders Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rohit Bhanot | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Nandan Mohan Chandavarkar | 0 | 0% | 2026-03-31 |
| Ameya Ashok Chandavarkar | 0 | 0% | 2026-03-31 |
| Aditi C Bhanot | 0 | 0% | 2026-03-31 |
| Nandan Mohan Chandavarkar (in The Capacity Of Trustee Mohan Anand Chandavarkar Trust) | 0 | 0% | 2026-03-31 |
| Nandan Mohan Chandavarkar (in The Capacity Of Trustee Sandhya Mohan Chandavarkar Trust) | 0 | 0% | 2026-03-31 |
| Nomita R Chandavarkar | 0 | 0% | 2026-03-31 |
| Meera Ramdas Chandavarkar | 0 | 0% | 2026-03-31 |
| Mohan Chandavarkar | 0 | 0% | 2026-03-31 |
| Sandhya Chandavarkar | 0 | 0% | 2026-03-31 |
| Alpana Nandan Chandavarkar | 0 | 0% | 2026-03-31 |
| Anandi Nandan Chandavarkar | 0 | 0% | 2026-03-31 |
| Shivani Nandan Chandavarkar | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Mohan A Chandavarkar | ED / MD / Promoter | 2025 |
| Nandan M Chandavarkar | Executive Director / JMD / WTD | 2025 |
| Ashok A Chandavarkar | WTD & Executive Director | 2025 |
| Ameya A Chandavarkar | ED / CEO - International Business / Promoter | 2025 |
| Nomita R Chandavarkar | Non-Exec & Non-Independent Dir | 2025 |
| Mahesh Bijlani | Independent Non Exe. Director | 2025 |
| Vijay Maniar | Independent Non Exe. Director | 2025 |
| Vijay N Bhatt | Independent Non Exe. Director | 2025 |
| Charuta Nityanath Mandke | Independent Non Exe. Director | 2025 |
| Varsharani Katre | CS / Compliance Officer / Legal Head | 2025 |
| Kishore Saletore | Additional Independent Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,794 Cr | 86.7% |
| USA | ₹64 Cr | 3.1% |
| Others | ₹212 Cr | 10.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 29 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-02-11 | ₹5 (500%) | Interim 1 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 8 | 0 | 0 | 16 | 64 | 87 |
| 2025 | 0 | 0 | 0 | 16 | 64 | 79 |
| 2025 | 8 | 0 | 0 | 0 | 0 | 8 |
Insider / Designated-Person Trades
5 recent disclosure(s)
Aditi C BhanotAcquisition · 99,56,821
Virgo Advisors Private LimitedDisposal · 99,56,821
Nomita Ramdas ChandavarkarAcquisition · 3,16,56,049
Meera Ramdas ChandavarkarDisposal · 3,16,56,049
Melarkode Ganesan ParmeswaranAcquisition · 3,700
Substantial Acquisitions (SAST)
6 disclosure(s)
Inter-se Transfer17/02/2026 · 99,56,821
Inter-se Transfer17/02/2026 · 99,56,821
-17/02/2026 · 99,56,821
NULL17/02/2026 · 99,56,821
Off Market / Inter se transfer27/03/2024 · 3,16,56,049
Off Market / Inter se transfer27/03/2024 · 3,16,56,049
Company Information
🌐 www.fdcindia.com ↗
📍 B-8 MIDC Industrial Area, Waluj Dist, AURANGABAD, Maharashtra, 431136
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search